Colorectal cancer screening cuts death risk
Analysis based on 7 articles · First reported Aug 20, 2026 · Last updated Aug 21, 2026
The study reinforces the value of colorectal cancer screening, potentially increasing demand for screening tests and related medical services. It may also influence public health policies and funding for screening programs, benefiting companies and organizations involved in cancer diagnostics and prevention.
A study published in JAMA Network Open by researchers at Karolinska Institute and Umeå University in Sweden found that active participation in colorectal cancer screening is associated with a 43% lower risk of dying from the disease, while receiving an invitation is associated with a 26% lower risk. The findings are based on up to 14 years of follow-up data from the Sweden — Stockholm-Sweden — Gotland screening programme, which began in 2008. The study included 376,511 people and recorded 1,668 deaths from colorectal cancer. The researchers used statistical methods to adjust for contamination bias and nonadherence. The study was funded by the American Cancer Society, the Sweden — Swedish Research Council, and Sweden — Stockholm County.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard